Aim and Scope

Drug Discovery and Development is an international, peer-reviewed journal dedicated to publishing high-quality original research articles, reviews, short communications, perspectives, and translational studies in all areas of modern drug discovery, pharmaceutical innovation, and therapeutic development. The journal provides a multidisciplinary platform for scientists, clinicians, pharmacologists, medicinal chemists, biotechnologists, computational biologists, and industrial researchers engaged in the discovery, optimization, evaluation, and clinical translation of novel therapeutic agents for human and veterinary applications.

The journal aims to advance scientific understanding of molecular targets, therapeutic mechanisms, drug design strategies, and innovative pharmaceutical technologies that contribute to the prevention, diagnosis, and treatment of diseases. It welcomes cutting-edge research in medicinal chemistry, rational drug design, computational chemistry, molecular docking, virtual screening, pharmacology, toxicology, pharmacokinetics/pharmacodynamics (PK/PD), ADMET prediction, safety pharmacology, and biomarker discovery. Particular emphasis is placed on emerging and transformative technologies in pharmaceutical sciences, including artificial intelligence (AI), machine learning, explainable AI, large language models, systems pharmacology, precision medicine, multi-omics integration, and digital therapeutics that are reshaping contemporary drug discovery pipelines.

The scope of the journal encompasses structure-based and ligand-based drug design, pharmacogenomics, personalized therapeutics, biologics, biosimilars, peptides, monoclonal antibodies, nucleic acid therapeutics, gene therapy, cell therapy, RNA therapeutics, genome editing technologies, nanomedicine, advanced drug delivery systems, natural products, and bioactive compounds. The journal also welcomes studies related to drug repurposing, translational medicine, preclinical and clinical drug development, clinical trials, regulatory science, pharmaceutical policy, radiopharmaceuticals, vaccine discovery, immune therapeutics, biotechnology-driven therapeutic innovation, and pharmaceutical manufacturing, quality assurance, and regulatory compliance.

In addition, the journal encourages submissions addressing emerging infectious diseases, antimicrobial drug discovery, oncology therapeutics, neuropharmacology, metabolic disorders, rare diseases, targeted therapeutics, real-world evidence, data-driven therapeutics, and digital health technologies. Interdisciplinary and translational studies bridging basic research, clinical applications, and industrial innovation are particularly encouraged. The journal strongly supports research promoting sustainable, ethical, reproducible, and patient-centred therapeutic development.

Drug Discovery and Development seeks to foster scientific excellence and global collaboration among academic institutions, healthcare organizations, regulatory agencies, and the pharmaceutical and biotechnology industries. The journal aims to accelerate the dissemination of innovative discoveries and technological advances that contribute to the development of safer, more effective, and accessible therapeutic solutions worldwide.

The journal is indexed in Google Scholar, Citationbase, PhcogBase, Index Pharmacus, SCIENBASE, Sci-Lit and Dimensions.